<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="covidseq/PMC7101506/results/search/disease/results.xml">
  <result pre="https://jamanetwork.com/journals/cardiology/fullarticle/10.1001/jamacardio.2020.1017 This case series study evaluates the association of underlying" exact="cardiovascular disease" post="and myocardial injury on fatal outcomes in patients with"/>
  <result pre="(COVID-19). Key Points Question What is the impact of underlying" exact="cardiovascular disease" post="(CVD) and myocardial injury on fatal outcomes in patients"/>
  <result pre="outcome is scarce. Objective To evaluate the association of underlying" exact="cardiovascular disease" post="(CVD) and myocardial injury with fatal outcomes in patients"/>
  <result pre="years. Overall, 66 (35.3%) had underlying CVD including hypertension, coronary" exact="heart disease," post="and cardiomyopathy, and 52 (27.8%) exhibited myocardial injury as"/>
  <result pre="China Introduction Coronavirus disease 2019 (COVID-19) is a newly recognized" exact="infectious disease" post="that has spread rapidly throughout Wuhan, Hubei, China, to"/>
  <result pre="clinical data, in addition to the common clinical presentation of" exact="respiratory failure" post="caused by COVID-19, the cardiovascular manifestations induced by this"/>
  <result pre="present, specific information characterizing whether patients with COVID-19 with underlying" exact="cardiovascular disease" post="(CVD) who develop myocardial injury during hospitalization face greater"/>
  <result pre="187 patients, 66 (35.3%) had underlying CVD including hypertension, coronary" exact="heart disease," post="and cardiomyopathy, and 52 (27.8%) exhibited myocardial injury as"/>
  <result pre="by elevated TnT levels. On admission, none showed evidence of" exact="acute myocardial infarction," post="chronic liver disease, thromboembolic diseases, or rheumatism. In patients"/>
  <result pre="On admission, none showed evidence of acute myocardial infarction, chronic" exact="liver disease," post="thromboembolic diseases, or rheumatism. In patients with elevated plasma"/>
  <result pre="&amp;lt;.001 COPD 4 (2.1) 0 (0) 4 (7.7) .001 Malignant" exact="neoplasm" post="13 (7.0) 7 (5.2) 6 (11.5) .13 Chronic kidney"/>
  <result pre="Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARDS," exact="acute respiratory distress syndrome;" post="CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease;"/>
  <result pre="angiotensin receptor blocker; ARDS, acute respiratory distress syndrome; CHD, coronary" exact="heart disease;" post="COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019;"/>
  <result pre="ARDS, acute respiratory distress syndrome; CHD, coronary heart disease; COPD," exact="chronic obstructive pulmonary disease;" post="COVID-19, coronavirus disease 2019; NA, not applicable; TnT, troponin"/>
  <result pre="of comorbidities including hypertension (33 [63.5%] vs 28 [20.7%]), coronary" exact="heart disease" post="(17 [32.7%] vs 4 [3.0%]), cardiomyopathy (8 [15.4%] vs"/>
  <result pre="28 [20.7%]), coronary heart disease (17 [32.7%] vs 4 [3.0%])," exact="cardiomyopathy" post="(8 [15.4%] vs 0), diabetes (16 [30.8%] vs 12"/>
  <result pre="(8 [15.4%] vs 0), diabetes (16 [30.8%] vs 12 [8.9%])," exact="chronic obstructive pulmonary disease" post="(4 [7.7%] vs 0), and chronic kidney disease (1"/>
  <result pre="[8.9%]), chronic obstructive pulmonary disease (4 [7.7%] vs 0), and" exact="chronic kidney disease" post="(1 [0.7%] vs 5 [9.6%]). Rates of smoking and"/>
  <result pre="TnT levels developed more frequent complications ( Table 1), including" exact="acute respiratory distress syndrome" post="(30 [57.7%] vs 16 [11.9%]), malignant arrhythmias (6 [11.5%]"/>
  <result pre="of COVID-19. For patients with underlying CVD, including hypertension, coronary" exact="heart disease," post="and cardiomyopathy, viral illness can further damage myocardial cells"/>
  <result pre="previous report showed that in 35% of the patients with" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) infection, the SARS-CoV genome was positively detected"/>
  <result pre="showed a beneficial effect of ACEI/ARB in patients admitted with" exact="viral pneumonia," post="as it significantly reduced the pulmonary inflammatory response and"/>
  <result pre="Lu H , Stratton CW , Tang YW Outbreak of" exact="pneumonia" post="of unknown etiology in Wuhan, China: the mystery and"/>
  <result pre="HD , Fauci AS Coronavirus infections: more than just the" exact="common cold." post="JAMA. Published online January 23, 2020. doi: 10.1001/jama.2020.0757 31971553"/>
  <result pre="10.1001/jama.2020.0757 31971553 4 Wuhan Municipal Health Commission. Report of clustering" exact="pneumonia" post="of unknown etiology in Wuhan City. Published December 31,"/>
  <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China . JAMA. Published February 7, 2020."/>
  <result pre="Investigating and Research Team A Novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med. 2020; 382("/>
  <result pre="White HD Impact of angiotensin-converting enzyme inhibitors and statins on" exact="viral pneumonia." post="Proc (Bayl Univ Med Cent). 2018; 31( 4): 419-"/>
 </snippets>
</snippetsTree>
